tiprankstipranks
TherapeuticsMD (TXMD)
NASDAQ:TXMD
US Market
TXMD
TherapeuticsMD
RESEARCH TOOLSreports

TherapeuticsMD (TXMD) Financial Statements

2,247 Followers

TherapeuticsMD Financial Overview

TherapeuticsMD's market cap is currently $23.73M. The company's EPS TTM is $-0.054; its P/E ratio is -33.14; TherapeuticsMD is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total Revenue$ 3.02M$ 1.76M$ 1.30M$ 69.96M$ 2.57M
Gross Profit$ 1.83M$ 1.76M$ 1.30M$ 68.57M$ 1.17M
Operating Income$ -4.21M$ -4.76M$ -8.52M$ 1.19M$ -79.58M
EBITDA$ -3.02M$ -2.98M$ -8.08M$ 11.86M$ -70.84M
Net Income$ -569.00K$ -2.18M$ -10.28M$ 112.00M$ -172.41M
Balance Sheet
Cash & Short-Term Investments$ 7.48M$ 5.06M$ 4.33M$ 38.07M$ 64.91M
Total Assets$ 37.66M$ 38.82M$ 43.31M$ 90.46M$ 169.47M
Total Debt$ 5.12M$ 7.17M$ 8.01M$ 8.76M$ 197.69M
Net Debt$ -2.36M$ 2.12M$ 3.68M$ -29.31M$ 132.79M
Total Liabilities$ 10.78M$ 11.45M$ 14.02M$ 55.31M$ 263.09M
Stockholders' Equity$ 26.88M$ 27.37M$ 29.29M$ 35.14M$ -93.62M
Cash Flow
Free Cash Flow$ 2.45M$ 732.00K$ 0.00$ -4.43M$ -147.84M
Operating Cash Flow$ 2.45M$ 732.00K$ -48.14M$ -4.08M$ -147.81M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 223.48M$ -2.22M
Financing Cash Flow$ 0.00$ 0.00$ 3.15M$ -235.21M$ 134.67M
Currency in USD

TherapeuticsMD Earnings and Revenue History

Income Statement >

TherapeuticsMD Debt to Assets

Balance Sheet >

TherapeuticsMD Cash Flow

Cash Flow >

TherapeuticsMD Forecast EPS vs Actual EPS

Earnings >